Bonus Biogroup Price To Book vs. Shares Outstanding
| BONS Stock | ILS 10.80 0.00 0.00% |
For Bonus Biogroup profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bonus Biogroup to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bonus Biogroup utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bonus Biogroup's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bonus Biogroup over time as well as its relative position and ranking within its peers.
Bonus |
Bonus Biogroup Shares Outstanding vs. Price To Book Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Bonus Biogroup's current stock value. Our valuation model uses many indicators to compare Bonus Biogroup value to that of its competitors to determine the firm's financial worth. Bonus Biogroup is number one stock in price to book category among its peers. It also is number one stock in shares outstanding category among its peers creating about 344,969,868 of Shares Outstanding per Price To Book. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bonus Biogroup by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bonus Biogroup's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Bonus Shares Outstanding vs. Price To Book
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Bonus Biogroup |
| = | 3.39 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Bonus Biogroup |
| = | 1.17 B |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Bonus Shares Outstanding Comparison
Bonus Biogroup is currently under evaluation in shares outstanding category among its peers.
Bonus Biogroup Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Bonus Biogroup, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bonus Biogroup will eventually generate negative long term returns. The profitability progress is the general direction of Bonus Biogroup's change in net profit over the period of time. It can combine multiple indicators of Bonus Biogroup, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd., formerly known as Oceana Advanced Industries Ltd., was founded in 1981 and is based in Haifa, Israel. BONUS BIOGROUP is traded on Tel Aviv Stock Exchange in Israel.
Bonus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Bonus Biogroup. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bonus Biogroup position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bonus Biogroup's important profitability drivers and their relationship over time.
Use Bonus Biogroup in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bonus Biogroup position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bonus Biogroup will appreciate offsetting losses from the drop in the long position's value.Bonus Biogroup Pair Trading
Bonus Biogroup Pair Trading Analysis
The ability to find closely correlated positions to Bonus Biogroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bonus Biogroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bonus Biogroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bonus Biogroup to buy it.
The correlation of Bonus Biogroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bonus Biogroup moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bonus Biogroup moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bonus Biogroup can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Bonus Biogroup position
In addition to having Bonus Biogroup in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alternative Energy Thematic Idea Now
Alternative Energy
Large and mid-size companies, ETFs and funds that are either investing or directly involved in providing energy derived from sources not connected to fossil fuels, do not consume natural resources, and do not harm the environment. This includes wind power, nuclear and solar energy, biofuel, ethanol, hydrogen and others alternative sources of energy. The Alternative Energy theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alternative Energy Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Bonus Stock
To fully project Bonus Biogroup's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bonus Biogroup at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bonus Biogroup's income statement, its balance sheet, and the statement of cash flows.